Robinson Chandler bought MNPR
September 24, 2026 · Form 4 insider transaction
Robinson Chandler bought 15,000 shares of Monopar Therapeutics Inc. at $14.00 per share, a transaction worth $210.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$14.00
Total value
$210.0K
InsiderRobinson Chandler
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 24, 2026
Filing dateSeptember 28, 2026
Shares owned after128,323
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on June 25, 2026.